Medinex (Catalist:OTX) has had a great run on the share market with its stock up by a significant 12% over the last month. However, in this article, we decided to focus on its weak fundamentals, as long-term financial performance of a business is what ultimately dictates market outcomes. In this article, we decided to focus on Medinex’s ROE.
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Put another way, it reveals the company’s success at turning shareholder investments into profits.
View our latest analysis for Medinex
ROE can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity
So, based on the above formula, the ROE for Medinex is:
9.1% = S$1.5m ÷ S$16m (Based on the trailing twelve months to September 2024).
The ‘return’ is the amount earned after tax over the last twelve months. Another way to think of that is that for every SGD1 worth of equity, the company was able to earn SGD0.09 in profit.
So far, we’ve learned that ROE is a measure of a company’s profitability. Depending on how much of these profits the company reinvests or “retains”, and how effectively it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.
When you first look at it, Medinex’s ROE doesn’t look that attractive. However, given that the company’s ROE is similar to the average industry ROE of 9.1%, we may spare it some thought. Having said that, Medinex’s five year net income decline rate was 23%. Bear in mind, the company does have a slightly low ROE. So that’s what might be causing earnings growth to shrink.
That being said, we compared Medinex’s performance with the industry and were concerned when we found that while the company has shrunk its earnings, the industry has grown its earnings at a rate of 5.8% in the same 5-year period.
Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. This then helps them determine if the stock is placed for a bright or bleak future. Is Medinex fairly valued compared to other companies? These 3 valuation measures might help you decide.
